Acute pancreatitis following liver transplantation
- PMID: 7545514
Acute pancreatitis following liver transplantation
Abstract
Background: Acute pancreatitis (AP) has not been recognized as a frequent complication following orthotopic liver transplantation (OLT). Reports have suggested that this condition is associated with high morbidity and mortality rates.
Study design: A retrospective review of 354 patients who underwent OLT at the University of Toronto, with at least one-year follow-up, was done to identify the incidence, etiology, risk factors, and severity of pancreatitis following OLT, as well as to discuss its management. A possible correlation between AP and hepatitis B was also investigated. Prognostic score systems, including Ranson, Imrie, and APACHE II, were also evaluated.
Results: Acute pancreatitis occurred in 5.9 percent of the OLT recipients. Based on clinical presentation and diagnostic tests, AP could be subdivided into three distinct categories: biochemical AP, significant increase of serum amylase or lipase levels in absence of objective radiologic or surgical evidence of the disease; clinical AP, pancreatitis with radiologic or surgical evidence of the disease; and AP in the critically ill patient. Biochemical AP occurred in the early postoperative period and was consistently a benign condition. Clinical AP occurred after a delay and was associated with a 40 percent mortality rate. Acute pancreatitis in the critically ill patient was only one component of multiorgan failure, which was lethal in each case. About one-half of the patients with biochemical and clinical AP were hepatitis surface antigen positive prior to OLT. The incidence of AP was significantly higher in patients with hepatitis B (17 percent) than in patients without hepatitis B (3 percent) (p < 0.01). APACHE II was the best prognostic score system in the clinical group with a positive and negative predictive value for a score equal to or greater than 10 points of 67 and 100 percent, respectively.
Conclusions: Acute pancreatitis is not an uncommon complication of OLT. Clinical presentation and diagnostic tests have important prognostic values. In some patients, hepatitis B virus may play an important role. APACHE II scores appear to be useful in the evaluation of clinical AP following OLT. Treatment of AP should be similar in both the transplant and nontransplant setting.
Similar articles
-
Acute pancreatitis in intensive care unit patients: value of clinical and radiologic prognosticators at predicting clinical course and outcome.Crit Care Med. 2003 Apr;31(4):1026-30. doi: 10.1097/01.CCM.0000049951.77583.85. Crit Care Med. 2003. PMID: 12682467
-
Intensive care management of acute pancreatitis: recognition of patients at high risk of developing severe or fatal complications.Wien Klin Wochenschr. 1996;108(1):9-15. Wien Klin Wochenschr. 1996. PMID: 8677661
-
Acute pancreatitis after cardiac transplantation and other cardiac procedures: case-control analysis in 24,631 patients.Am Surg. 1999 Sep;65(9):819-25; discussion 826. Am Surg. 1999. PMID: 10484083
-
[Diagnosis of acute pancreatitis].Helv Chir Acta. 1992 May;59(1):17-25. Helv Chir Acta. 1992. PMID: 1526824 Review. French.
-
Assessment of severity in acute pancreatitis.Am J Gastroenterol. 1991 Oct;86(10):1385-91. Am J Gastroenterol. 1991. PMID: 1928029 Review.
Cited by
-
Prolonged hepatic inflow occlusion to reduce bleeding during recipient hepatectomy in living donor liver transplantation.Korean J Transplant. 2020 Mar 31;34(1):55-61. doi: 10.4285/kjt.2020.34.1.55. Korean J Transplant. 2020. PMID: 35770262 Free PMC article.
-
Clinical relevance of acute pancreatitis in allogeneic hemopoietic stem cell (bone marrow or peripheral blood) transplants.Dig Dis Sci. 1999 Jun;44(6):1124-7. doi: 10.1023/a:1026611804261. Dig Dis Sci. 1999. PMID: 10389682
-
Liver resection volume-dependent pancreatic strain following living donor hepatectomy.Sci Rep. 2024 Mar 21;14(1):6753. doi: 10.1038/s41598-024-57431-1. Sci Rep. 2024. PMID: 38514681 Free PMC article.
-
Glucagon-like peptide-1 receptor agonists in liver transplant recipients with diabetes: changes in glucose control and cardiometabolic risk factors.Front Endocrinol (Lausanne). 2025 May 27;16:1586941. doi: 10.3389/fendo.2025.1586941. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40496570 Free PMC article.
-
Case report: GLP1RA for the treatment of diabetes in liver transplanted people. Do they increase the risk of pancreatitis?Front Endocrinol (Lausanne). 2024 May 8;15:1392371. doi: 10.3389/fendo.2024.1392371. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38779453 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical